Terminated PHASE2 INTERVENTIONAL 2-arm NCT03786302

Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth

Comparison of the Regenerative Ability of Tailored Amorphous Multiporous Bioglass and Biodentine in Pulpotomized Primary Teeth

Sponsor: Alexandria University

Conditions Pulpotomy

Interventions Biodentine TAMP bioglass

Updated 7 times since 2019 Last updated: Oct 11, 2020 Started: Dec 6, 2016 Primary completion: Aug 15, 2018 Completion: Oct 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Failure rate was 100% in one arm of the study (the intervention)

Other terminated trials from Alexandria University

See all terminations from Alexandria University

Listed as NCT03786302, this PHASE2 trial focuses on Pulpotomy and remains terminated or withdrawn. Sponsored by Alexandria University, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE2
Oct 2019 — Nov 2020 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Apr 2019 — Oct 2019 [monthly]

Terminated PHASE2
Jan 2019 — Apr 2019 [monthly]

Terminated PHASE2

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexandria University
Nourhan M.Aly

Data source: University of Alexandria

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt